Home / Health / BC Babies Face Huge RSV Shot Costs
BC Babies Face Huge RSV Shot Costs
18 Nov, 2025
Summary
- Infant RSV immunization costs $800-$900 out-of-pocket in B.C.
- Most Canadian provinces offer the RSV vaccine free to infants.
- RSV hospitalizations cost nearly $32.5 million annually in Canada.
An immunization for respiratory syncytial virus (RSV) is now accessible in Canada, yet most parents in British Columbia must pay a substantial price out-of-pocket. Nirsevimab, known as Beyfortus, was approved in April 2023 and recommended for all infants during their first RSV season. While available for $800 to $900, its coverage is limited in B.C., Alberta, and New Brunswick, with only specific high-risk infants or those in remote communities qualifying for public funding.
RSV typically causes mild cold symptoms but can lead to severe illness in newborns and vulnerable populations. A study revealed that infants under six months accounted for nearly 45% of RSV-related hospital admissions in Canada. This highlights the significant risk to young infants who cannot effectively combat the virus, leading to frequent hospitalizations and considerable healthcare costs, estimated at around $32.5 million annually.
The National Advisory Committee on Immunization recommended prioritizing coverage for higher-risk infants due to the vaccine's high price, while also advocating for a universal program. Provinces ultimately decide on medication coverage. The B.C. Ministry of Health stated they review eligibility annually, with 4,000 doses allocated for high-risk infants for the upcoming season, while advocating for broader provincial coverage could prove economically beneficial.
